Bain Capital Life Sciences

HeartFlow Raises $215M for AI-Powered Cardiac Test

by Leave a Comment

What You Should Know: - HeartFlow, Inc., a provider of precision heart care raises $215M in Series F funding round led by Bain Capital Life Sciences with participation from new investor Janus Henderson Investors, and existing investors including Baillie Gifford, Capricorn Investment Group, Hayfin Capital Management, HealthCor, Martis Capital, USVP and Wellington Management. - HeartFlow’s non-invasive personalized cardiac test provides unprecedented visualization of each patient’s coronary
Read More

Pfizer Spin Off Lands $103M to Develop New Drugs for Undeserved Patient Populations

by Leave a Comment

SpringWorks Therapeutics, a new Pfizer spin-off launched as a way to advance investigational drug therapies that may hold significant promise for underserved patients has raised $103 million in funding in Series A funding. The Series A round was led by Bain Capital Life Sciences, Bain Capital Double Impact, OrbiMed, Pfizer and LifeArc (formerly known as MRC Technology). SpringWorks Therapeutics’ collaborative business model is designed to deliver both social and financial returns via
Read More